Sanofi SA

SAN: XPAR (FRA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|z&LOCK|mX&MTLOCK|N&rkctR

Sanofi Earnings: Strong Earnings Growth Supports Optimistic Full-Year Guidance

Sanofi reported net sales growth of 7% at constant currency and business earnings per share growth of 13%. Despite lower flu vaccine sales, Dupixent and Altuviiio continued to drive growth, and management reiterated its full-year guidance of low-double-digit business EPS growth.

Sponsor Center